AstraZeneca PLC company logo
AstraZeneca PLC logo

AstraZeneca PLC (AZN) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$5.49B$352.00M-6.03%

Summary

Current Value
As of today, AZN annual cash & cash equivalents is $5.49B, down -6.03% on
Historical Performance
AZN annual cash & cash equivalents is down -13.29% over the past 3 years, and up +2.24% over the past 5 years
All-Time High Comparison
AZN annual cash & cash equivalents is currently -48.70% below its historical high of $10.70B set on
3-Year Low Comparison
AZN annual cash & cash equivalents is at its 3-year low
Sector Comparison
AZN annual cash & cash equivalents is higher than 98.31% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AZN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$5.49B-6.0%-13.3%+2.2%-44.7%
Quarterly Cash & Cash Equivalents$8.18B+66.0%+67.0%-3.1%-29.3%
Price$91.57+38.2%+31.2%+80.6%+287.4%
Annual Current Assets$25.83B+3.1%-1.6%+66.0%+8.7%
Annual Total Liabilities$63.16B+1.9%-4.4%+35.0%+85.2%
Annual Working Capital-$2.04B+62.9%-155.9%+20.2%-133.3%
Annual Net Income$7.04B+18.2%+6025.2%+474.1%-6.1%

Cash and Cash Equivalents Highs

AZN Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$6.17BN/A-11.0%
5Y$7.83BN/A-29.9%
All$10.70B-48.7%

Cash and Cash Equivalents Lows

AZN Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$5.49Bat low
5Y$5.49Bat low
All$129.24M+4146.4%

Cash and Cash Equivalents History

YearValueChange
$5.49B-6.0%
$5.84B-5.3%
$6.17B-2.6%
$6.33B-19.2%
$7.83B+45.9%
$5.37B+13.1%
YearValueChange
$4.75B+42.7%
$3.32B-32.5%
$4.93B-19.6%
$6.13B-1.9%
$6.25B-

FAQ

  • What is the current annual cash & cash equivalents of AZN?

    As of today, AZN annual cash & cash equivalents is $5.49B

  • What is 1-year change in AZN annual cash & cash equivalents?

    AZN annual cash & cash equivalents is down -6.03% year-over-year

  • What is 3-year change in AZN annual cash & cash equivalents?

    AZN annual cash & cash equivalents is down -13.29% over the past 3 years

  • How far is AZN annual cash & cash equivalents from its all-time high?

    AZN annual cash & cash equivalents is currently -48.70% below its historical high of $10.70B set on December 31, 2010

  • How does AZN annual cash & cash equivalents rank versus sector peers?

    AZN annual cash & cash equivalents is higher than 98.31% of companies in Healthcare sector

  • When is AZN next annual earnings release?

    The next annual earnings release for AZN is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. AZN Official Website www.astrazeneca.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/901832/000165495425012630/0001654954-25-012630-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/901832/000110465925014750/0001104659-25-014750-index.htm
  4. AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
  5. AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn